Veracyte, Inc. (NASDAQ: VCYT) Stock Information | RedChip

Veracyte, Inc. (NASDAQ: VCYT)


$43.7500
-0.0300 ( +2.97% ) 633.1K

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Market Data


Open


$43.7500

Previous close


$43.7800

Volume


633.1K

Market cap


$3.39B

Day range


$41.8020 - $43.9490

52 week range


$18.6100 - $46.0000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
10-q Quarterly Reports 66 Aug 07, 2024
8-k 8K-related 15 Aug 06, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024

Latest News